Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors

Authors:

Lin, Huamao M, Pan, Xiaoyun, Hou, Peijie, Huang, Hui, Wu, Yanyu, Ren, Kaili, Jahanzeb, Mohammad

Journal

Journal of medical economics

Year

2020

Volume

May 21

Pages

1-8

Physicians